Monument Capital Management Makes New Investment in HCA Healthcare, Inc. $HCA

Key Points

• Monument Capital Management has invested approximately $234,000 in HCA Healthcare by acquiring 611 shares in the second quarter, highlighting growing institutional interest in the company.
• Wall Street analysts have mixed ratings on HCA Healthcare, with target prices ranging from $370.00 to $465.00; the average rating is currently labeled as a Moderate Buy.
• HCA Healthcare recently announced a quarterly dividend of $0.72 per share, reflecting an annualized payout of $2.88 and a dividend yield of 0.7%.

Monument Capital Management bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 611 shares of the company's stock, valued at approximately $234,000.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the 1st quarter worth about $26,000. Saudi Central Bank acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. WPG Advisers LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $27,000. Ameriflex Group Inc. acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on HCA. JPMorgan Chase & Co. upped their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Bank of America upped their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a research report on Wednesday, September 10th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. KeyCorp upped their target price on HCA Healthcare from $370.00 to $465.00 and gave the company an "overweight" rating in a research report on Wednesday. Finally, Robert W. Baird increased their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $422.31.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $414.73 on Friday. The business's 50 day simple moving average is $405.12 and its two-hundred day simple moving average is $375.58. The firm has a market cap of $97.04 billion, a P/E ratio of 17.43, a PEG ratio of 1.32 and a beta of 1.40. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the company earned $5.50 earnings per share. The company's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.